Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 101 to 125 of 2518

TitleReference numberPublishedLast updated
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessmentHTE25
Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphomaTA1059
Drug-eluting stents for treating coronary artery disease: late-stage assessmentHTE26
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal)TA1061
Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessmentHTE24
Suspected cancer: recognition and referralNG12
COVID-19 rapid guideline: managing COVID-19NG191
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19TA878
Slide sheets for moving or repositioning a person: late-stage assessmentHTE23
FallsQS86
Falls: assessment and prevention in older people and in people 50 and over at higher riskNG249
Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and overHST33
Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labourIPG800
Tislelizumab in combination for untreated advanced non-small-cell lung cancer (terminated appraisal)TA1058
Robot-assisted surgery for soft tissue procedures: early value assessmentHTE21
Robot-assisted surgery for orthopaedic procedures: early value assessmentHTE22
Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapyTA1055
Molnupiravir for treating COVID-19TA1056
Relugolix–estradiol–norethisterone for treating symptoms of endometriosisTA1057
Cladribine for treating active relapsing forms of multiple sclerosisTA1053
Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and overTA1054
Early and locally advanced breast cancer: diagnosis and managementNG101
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8
Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type BHST32
Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer (terminated appraisal)TA1052

Results per page

  1. 10
  2. 25
  3. 50
  4. All